Dividend Market Brief

• Market panic creates buys: Savvy investors accumulate high-yield defensive assets as others flee quality.
• 5 Dividend Kings/Aristocrats...

JNJ is drawing investor focus ahead of quarterly earnings, expecting $2.83 EPS—a +2.2% rise year-over-year. The Zacks outlook signals positivity for this dividend stalwart.

Largest U.S. Coca-Cola bottler Coca-Cola Consolidated invests $35M to add glass bottling at its Indianapolis facility—one of only three...

Post-earnings, Morningstar maintains Coca-Cola (KO) at a 3-star rating, deeming it fairly valued versus its long-term fair value estimate of $74. Steady for dividend investors.

Dividend Increases

• 🔥 Coca-Cola Q2 2026 Dividend: Coca-Cola raised its quarterly dividend approximately 4% to 53 cents per share from 51...

Key bottler move for stable dividend giant KO:

• $35M investment adds rare U.S. glass bottle line at Indy facility—one of only three.
• Creates 15-20 jobs; construction starts late 2026.
• Reinforces strategic growth in KO beverages across 14 states.

Timeless lesson from Buffett: In 1988, he bought $1.3 billion of Coca-Cola stock; by 1994, annual dividends alone nearly equaled the full cost. He...

Coca-Cola's Q1 revenue surged 12% to $12.47B, with 10% organic sales growth and 18% adjusted EPS rise; Zero Sugar sales jumped 13%.

• Q2 dividend...

JNJ shines as healthcare powerhouse with $546.9B market cap, focusing on oncology, immunology, and neuroscience innovations.

• Market beater: +47.1%...

JNJ Forever Stock Endorsements

• 🔥 Morningstar Watchlist: Morningstar lists Johnson & Johnson (JNJ) as one of three forever stocks for watchlists...

Pipeline boost for JNJ: CAPLYTA ranked highest across 4 key efficacy measures for adjunctive MDD vs. other FDA-approved antipsychotics—MADRS change MD...

Baron Health Care Fund increased its JNJ stake, highlighting portfolio shifts like Kenvue spin-off (2023) and Depuy Synthes plans (2025) for focus on...

• Oppenheimer Asset Management cut its JNJ holdings by 3.4%, selling 22,138 shares to hold 628,197 shares worth $130M (1.6% of portfolio).
• Insiders...

JNJ affirmed as top forever stock with one of the widest economic moats in healthcare, backed by IP, drug launches countering expirations, and...

Coca-Cola FEMSA Q1 revenue rose to MX$70.9B but net income fell to MX$4.3B YoY.

• Higher marketing, restructuring, IT, financing costs and Mexico...

• Investor shares $155K dividend portfolio update, focusing on 2026 market boom positioning.
• Highlights stable payers like Coca-Cola (KO), Johnson &...

Coca-Cola's unshakeable strengths for dividend investors:

• Dividend King with over 60 years of consecutive increases, questioning if it's still a...

Dividend brief: Sticky inflation and labor data ramp up yield pressures, challenging stability for KO, JNJ:

• ISM Manufacturing prices paid 84.4,...

Coca-Cola Femsa (KOF) Updates

• Moderate Buy Consensus: Brokerages assigned Coca-Cola Femsa (KOF) a consensus 'Moderate Buy' rating with 5 buys...

Coca-Cola Femsa (KOF), key KO bottler, gets Moderate Buy consensus (5 buys, 4 holds) with $113.60 target.

• Dividend boosted to $1.0873 quarterly...